Webinar | Weighing In: Unpacking new evidence in managing obesity and CVD | Heart Foundation
Chaired by Professor Garry Jennings, and joined by an expert panel, our latest health professional clinical webinar 'weighs in’ on the profound relationship between obesity and CVD.
In Australia, approximately 65% of individuals aged 15 and over are overweight or obese, significantly increasing their risk of CVD.
The causes of obesity are multifaceted, involving genetic, epigenetic, psychosocial, sociocultural, economic, and environmental factors. With obesity now recognised as a complex, chronic disease, our expert panel unpacks the latest research findings, epidemiology, and innovative treatment modalities for obesity and CVD.
In 90 minutes of live presentations and Q&A, the experts cover:
• Defining obesity as a complex chronic disease, including epidemiology, and pharmacological management.
• Understanding the SELECT trial and other GLP-1 medicines in obesity treatment and management.
• Exploring the role of Bariatric surgery in reducing weight and CVD risk.
• Evidenced-based lifestyle interventions for obesity.
• Practical strategies for optimising obesity and CVD risk factor management within the primary care setting.